Skip to content

Urologie

16/08/2023
Urologie

Discrimination, Reliability, Sensitivity, and Specificity of Robotic Surgical Proficiency Assessment With Global Evaluative Assessment of Robotic Skills and Binary Scoring Metrics: Results From a Randomized Controlled Trial.

Ann Surg Open. 2023 Aug 16;4(3):e307. doi: 10.1097/AS9.0000000000000307. eCollection 2023 Sep. PMID: 37746611 Free PMC article.dr. Uvin Pieter
08/07/2022
Urologie

Urethro-venous fistula following straddle injury: A case report and image series.

PMID: 36016722 PMCID: PMC9396026 DOI: 10.1016/j.eucr.2022.102184dr. D'hulst Pieter
10/03/2022
Urologie

Irrigation fluid absorption syndrome during HoLEP: A case study.

Urol Case Rep. 2022 Oct 3;45:102248. doi: 10.1016/j.eucr.2022.102248. eCollection 2022 Nov. PMID: 36238443dr. Uvin Pieter
01/01/2020
Urologie

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy.

Future Oncol 16(16):1083-9.dr. Uvin Pieter
01/01/2020
Urologie

TRPV4 Mediates Acute Bladder Responses to Bacterial Lipopolysaccharides.

Front. Immunol 11 :799. Article DOI: 10.3389/fimmu.2020.00799.dr. Uvin Pieter
06/12/2023
Urologie

The Effect of Surgical Experience on Perioperative and Oncological Outcomes After Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Evidence from a Referral Centre with Extensive Experience in Robotic Surgery.

Eur Urol Focus, accepted 12 Feb 2020,(Epub ahead of print), Article DOI 10.1016/j.euf.2020.01.016.dr. Uvin Pieter
01/01/2020
Urologie

Lifestyle among urology trainees and young urologist in the context of burn-out syndrome.

Actas Urol Esp 44(1):19-26.dr. Uvin Pieter
05/01/2020
Urologie

Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy.

Future Oncol. 2020 Jun;16(16):1083-1189. doi: 10.2217/fon-2020-0056. Epub 2020 May 1.Future Oncol. 2020. PMID: 32356465dr. Uvin Pieterdr. Ghysel Christophe
06/11/2019
Urologie

Time to Move On: The Impending Need for a New Disease-specific Comorbidity Index for Bladder Cancer Patients Undergoing Robot-assisted Radical Cystectomy.

Eur Urol Focus, accepted Jun 11 2019, (Epub ahead of print), Article DOI: 10.1016/j.euf.2019.05.015dr. Uvin Pieter
10/01/2019
Urologie

106PElevated driver mutational burden or number of perturbed pathways and poor response to abiraterone or enzalutamide in metastatic castration-resistant prostate cancer.

Annals of Oncology. 2019 Oct 1;30 (Supplement_5).dr. Ghysel Christophe
07/01/2019
Urologie

Androgen Receptor Burden and Poor Response to Abiraterone or Enzalutamide in TP53 Wild-Type Metastatic Castration-Resistant Prostate Cancer.

JAMA Oncol. 2019 Jul 1;5(7):1060–2.dr. Ghysel Christophe
01/01/2018
Urologie

Chapter 38 : Robotic or Laparoscopic Renal Surgery: Pros and Cons. In: Hemal AK, Menon M. Robotics in Genitourinary Surgery.

Second Edition. ISBN: 978-3-319-20644-8. Springer International Publishing. Pagina’s 515-547.dr. Uvin Pieter
06/12/2023
Urologie

The use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: a prospective randomized cohort study.

Int J of Urol, accepted Nov 21 2018, (Epub ahead of print), Article DOI: 10.1111/iju.13883.dr. Uvin Pieter
01/01/2018
Urologie

Fatigue syndrome: Stress, Burnout and Depression in Urology.

Arch Esp Urol 71(1) :46-54.dr. Uvin Pieter
01/01/2018
Urologie

Assessment of the efficacy of repeated instillations of mitomycin C mixed with a thermosensitive hydrogel in an orthotopic rat bladder cancer model.

Ther Adv Urol. 2018;10:213-221dr. Arentsen Harm
06/12/2023
Urologie

Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis.

Genome Medicine; 2018 Nov 16;:1–13.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe
09/12/2018
Urologie

TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer.

Clinical Cancer Research. 2018 Sep 12;clincanres.1943.2018.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe
05/01/2018
Urologie

Circulating tumor cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

Prostate. 2018 May;78(6):435–45.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe
06/12/2023
Urologie

Circulating tumour cells and survival in abiraterone- and enzalutamide-treated patients with castration-resistant prostate cancer.

Journal of Clinical Oncology. American Society of Clinical Oncology; 2017 May 20;35(15_suppl):5049–9.dr. Bols Alaindr. Van Oyen Peterdr. Ampe Jozefdr. Ghysel Christophe

25 maart 2025

Update van de aanpak van hoofdpijnproblemen – De impact van…

22 oktober 2024

Informatiedag omtrent gehoorverlies en hooroplossingen

22 oktober 2024

Innovatieve behandelingen voor goedaardige prostaatvergroting

22 oktober 2024

Multidiscipliniaire aanpak van rectumkanker (niet gemetastaseerd)